Sarah J. Duff-Canning, PhD. - Publications

Affiliations: 
Krembil Neuroscience Centre University Health Network, Toronto, Toronto, Ontario, Canada 
Area:
Neuropsychology

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Kuhlman G, Auinger P, Duff-Canning S, Lang A, Tanner C, Marras C. Non-steroidal anti-inflammatory drug use and markers of Parkinson's disease progression: A retrospective cohort study. Journal of the Neurological Sciences. 454: 120822. PMID 37839283 DOI: 10.1016/j.jns.2023.120822  0.35
2023 Gasca-Salas C, Duff-Canning S, McArthur E, Armstrong MJ, Fox S, Meaney CA, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C, Marshall FJ, Mapstone M, Chou KL, Persad C, Litvan I, et al. Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up Study. Alzheimer Disease and Associated Disorders. PMID 37615480 DOI: 10.1097/WAD.0000000000000576  0.555
2020 Gasca-Salas C, Duff-Canning S, Armstrong MJ, Eslinger PJ, Schneider RB, Kennedy N, Chou KL, Persad C, Litvan I, Weintraub S, Marras C. Parkinson disease with mild cognitive impairment: domain-specific cognitive complaints predict dementia. Acta Neurologica Scandinavica. PMID 32740919 DOI: 10.1111/Ane.13326  0.541
2019 Faust-Socher A, Duff-Canning S, Grabovsky A, Armstrong MJ, Rothberg B, Eslinger PJ, Meaney CA, Schneider RB, Tang-Wai DF, Fox SH, Zadikoff C, Kennedy N, Chou KL, Persad C, Litvan I, et al. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease. Dementia and Geriatric Cognitive Disorders. 1-11. PMID 31315127 DOI: 10.1159/000496454  0.588
2019 AlDakheel A, Gasca-Salas C, Armstrong MJ, Duff-Canning S, Marras C. Cognitive Complaints in Nondemented Parkinson's Disease Patients and Their Close Contacts do not Predict Worse Cognitive Outcome. Alzheimer Disease and Associated Disorders. PMID 30958414 DOI: 10.1097/Wad.0000000000000301  0.588
2018 Shirzadi Z, Robertson AD, Metcalfe AW, Duff-Canning S, Marras C, Lang AE, Masellis M, MacIntosh BJ. Brain tissue pulsatility is related to clinical features of Parkinson's disease. Neuroimage. Clinical. 20: 222-227. PMID 30090696 DOI: 10.1016/J.Nicl.2018.07.017  0.427
2017 Cho SS, Strafella AP, Duff-Canning S, Zurowski M, Vijverman AC, Bruno V, Aquino CC, Criaud M, Rusjan PM, Houle S, Fox SH. The Relationship Between Serotonin-2A Receptor and Cognitive Functions in Nondemented Parkinson's Disease Patients with Visual Hallucinations. Movement Disorders Clinical Practice. 4: 698-709. PMID 30363421 DOI: 10.1002/mdc3.12466  0.401
2016 Fasano A, Appel-Cresswell S, Jog M, Zurowkski M, Duff-Canning S, Cohn M, Picillo M, Honey CR, Panisset M, Munhoz RP. Medical Management of Parkinson's Disease after Initiation of Deep Brain Stimulation. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 43: 626-34. PMID 27670207 DOI: 10.1017/Cjn.2016.274  0.402
2016 Metcalfe AW, Udow S, Sharmarke H, Shirzadi Z, Long D, Duff-Canning S, Marras C, Lang AE, MacIntosh BJ, Masellis M. P4-169: Cognitive Performance and Functional Connectivity are Modulated by Striatal Dopaminergic Deficit in Adults With Parkinson’s Disease Alzheimer's & Dementia. 12: P1082-P1082. DOI: 10.1016/J.Jalz.2016.06.2261  0.46
2016 Shirzadi Z, Sharmarke H, Robertson AD, Metcalfe AW, Duff-Canning S, Marras C, Lang AE, Masellis M, MacIntosh BJ. P3-244: Elevated Physiological Fluctuations in White Matter is Related to Disease Severity in Patients with Parkinson's Disease Alzheimer's & Dementia. 12: P920-P922. DOI: 10.1016/J.Jalz.2016.06.1906  0.4
2015 Armstrong MJ, Duff-Canning S, Psych C, Kowgier M, Marras C. Independent application of montreal cognitive assessment/mini-mental state examination conversion. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1710-1. PMID 25820874 DOI: 10.1002/Mds.26221  0.302
2015 Christopher L, Duff-Canning S, Koshimori Y, Segura B, Boileau I, Chen R, Lang AE, Houle S, Rusjan P, Strafella AP. Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease. Annals of Neurology. 77: 269-80. PMID 25448687 DOI: 10.1002/Ana.24323  0.508
2015 Koshimori Y, Segura B, Christopher L, Lobaugh N, Duff-Canning S, Mizrahi R, Hamani C, Lang AE, Aminian K, Houle S, Strafella AP. Imaging changes associated with cognitive abnormalities in Parkinson's disease. Brain Structure & Function. 220: 2249-61. PMID 24816399 DOI: 10.1007/S00429-014-0785-X  0.57
2014 Christopher L, Marras C, Duff-Canning S, Koshimori Y, Chen R, Boileau I, Segura B, Monchi O, Lang AE, Rusjan P, Houle S, Strafella AP. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment. Brain : a Journal of Neurology. 137: 565-75. PMID 24334314 DOI: 10.1093/Brain/Awt337  0.55
2013 Reginold W, Duff-Canning S, Meaney C, Armstrong MJ, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Marshall F, Mapstone M, Chou KL, Persad C, Litvan I, et al. Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease. Dementia and Geriatric Cognitive Disorders. 36: 67-75. PMID 23774742 DOI: 10.1159/000350032  0.529
2013 Marras C, Armstrong MJ, Meaney CA, Fox S, Rothberg B, Reginold W, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C, Kennedy N, Marshall FJ, Mapstone M, Chou KL, Persad C, ... ... Duff-Canning S, et al. Measuring mild cognitive impairment in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 626-33. PMID 23520128 DOI: 10.1002/Mds.25426  0.584
2013 Armstrong MJ, Duff-Canning S, Tang-Wai DF, Fox S, Zadikoff C, Kennedy N, Gill D, Eslinger PJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Marras C. The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease. Parkinsonism & Related Disorders. 19: 463-5. PMID 23036511 DOI: 10.1016/J.Parkreldis.2012.09.005  0.535
2012 Armstrong MJ, Naglie G, Duff-Canning S, Meaney C, Gill D, Eslinger PJ, Zadikoff C, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Fox S, Tang-Wai DF, Marras C. Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders Extra. 2: 343-52. PMID 22962558 DOI: 10.1159/000341782  0.547
2012 Reginold W, Armstrong MJ, Duff-Canning S, Lang A, Tang-Wai D, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Mapstone M, Chou K, Persad C, Litvan I, et al. The pill questionnaire in a nondemented Parkinson's disease population. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1308-11. PMID 22865587 DOI: 10.1002/Mds.25124  0.548
2008 Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, Bie RMAd, Wadia P, Miyasaki J, Duff-Canning S, Lang AE, Marras C. A comparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease Movement Disorders. 23: 297-299. PMID 18044697 DOI: 10.1002/Mds.21837  0.585
2007 Voon V, Thomsen T, Miyasaki JM, Souza Md, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M. Factors Associated With Dopaminergic Drug-Related Pathological Gambling in Parkinson Disease Jama Neurology. 64: 212-216. PMID 17296836 DOI: 10.1001/Archneur.64.2.212  0.428
2006 Voon V, Hassan K, Zurowski M, Duff-Canning S, Souza Md, Fox S, Lang AE, Miyasaki J. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology. 66: 1750-1752. PMID 16769956 DOI: 10.1212/01.Wnl.0000218206.20920.4D  0.447
Show low-probability matches.